Piero Crespo

9PUBLICATIONS
24CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Supramolecular chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 11, 2025
Identification and Characterization of ERK2 Dimerization Inhibitors by Integrated In Silico and In Vitro Screening.

Carmen Ortiz-González, Berta Casar, Rafael Gozalbes

|Sep 12, 2024
ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility.

Dalia de la Fuente-Vivas, Vincenzo Cappitelli, Rocío García-Gómez

|Aug 09, 2024
The mevalonate pathway contributes to breast primary tumorigenesis and lung metastasis.

Javier Conde, Isabel Fernández-Pisonero, L Francisco Lorenzo-Martín

|Jul 18, 2023
ERK2 stimulates MYC transcription by anchoring CDK9 to the MYC promoter in a kinase activity-independent manner.

Lorena Agudo-Ibáñez, Marta Morante, Lucía García-Gutiérrez

|Feb 15, 2023
Scaffold coupling: ERK activation by trans-phosphorylation across different scaffold protein species.

Ana Martín-Vega, Laura Ruiz-Peinado, Rocío García-Gómez

Pageof 2